Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07328948 in Adults With Heart Failure (BRANCH-HF)
NCT06991257Phase 2Recruiting
- Sponsor
- Pfizer
- Start
- Jun 2025
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of PF-07328948 in heart failure (HF), sponsored by Pfizer. Started Jun 2025; status: recruiting.
02
Drugs
PF-07328948
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06991257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06991257.